Tumor-Induced Myeloid Dysfunction and Its Implications for Cancer Immunotherapy

Cancer Immunology, Immunotherapy - Germany
doi 10.1007/s00262-014-1639-3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC